<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04406051</url>
  </required_header>
  <id_info>
    <org_study_id>nor-cryst vs. nor-coll</org_study_id>
    <nct_id>NCT04406051</nct_id>
  </id_info>
  <brief_title>Prevention of Maternal Hypotension During Cesarean Section With Norepinephrine Infusion.</brief_title>
  <acronym>annie-manos</acronym>
  <official_title>Prevention of Maternal Hypotension During Cesarean Section With Norepinephrine Infusion. Does Time and Type of Administered Fluids Matter?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aretaieion University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alexandra Hospital, Athens, Greece</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aretaieion University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a randomized study aiming at investigating the combination of a norepinephrine&#xD;
      infusion and colloid preloading versus the combination of a norepinephrine infusion and&#xD;
      crystalloid co-loading for the prevention of maternal hypotension during elective cesarean&#xD;
      section&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neuraxial techniques are the anesthetic techniques of choice in contemporary obstetric&#xD;
      anesthesia practice, with a definitive superiority as compared to general anesthesia, since,&#xD;
      by their use, serious complications involving the airway can be avoided.Spinal anesthesia has&#xD;
      become the favorable technique for both elective and emergency cesarean section due to a&#xD;
      quick and predictable onset of action, however, it can be frequently complicated by&#xD;
      hypotension, with incidence exceeding 80% occasionally. Recently, noradrenaline has been&#xD;
      shown to be effective in maintaining blood pressure in obstetric patients. Another technique&#xD;
      widely used to prevent hypotension is fluid administration. Current evidence suggests that&#xD;
      the combination of fluid administration and vasoconstrictive medications should be the main&#xD;
      strategy for prevention and management of hypotension accompanying neuraxial anesthesia&#xD;
      procedures during cesarean section. Research is still underway in relation to the most&#xD;
      appropriate timing for fluid administration, the most appropriate fluid volume as well as the&#xD;
      type of fluid that should be administered. However, preloading of crystalloids seems to be&#xD;
      inefficient as a sole strategy, while co-loading of colloids is more effective than&#xD;
      co-loading of crystalloids for prevention of hypotension in the parturient. On the other&#xD;
      hand, preloading and co-loading of colloids seem to be of equal effectiveness. Literature is&#xD;
      rather scarce regarding the comparison of colloid preloading and crystalloid co-loading.&#xD;
&#xD;
      The aim of this randomized study will be to investigate the combination of a norepinephrine&#xD;
      infusion and colloid preloading versus the combination of a norepinephrine infusion and&#xD;
      crystalloid co-loading for the prevention of maternal hypotension during elective cesarean&#xD;
      section.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 26, 2020</start_date>
  <completion_date type="Actual">April 30, 2021</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of hypotension</measure>
    <time_frame>intraoperative</time_frame>
    <description>any occurence of hypotension (systolic blood pressure&lt;80% of baseline) throughout the operation will be recorded</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>need for vasoconstrictor</measure>
    <time_frame>intraoperative</time_frame>
    <description>any need for vasoconstrictor during the operation will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>type of vasoconstrictor administered</measure>
    <time_frame>intraoperative</time_frame>
    <description>phenylephrine versus ephedrine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total dose of vasoconstrictor administered</measure>
    <time_frame>intraoperative</time_frame>
    <description>total dose in mg for ephedrine or Î¼g for phenylephrine administered</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of hypertension</measure>
    <time_frame>intraoperative</time_frame>
    <description>any incidence of systolic blood pressure&gt;120% of baseline will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of bradycardia</measure>
    <time_frame>intraoperative</time_frame>
    <description>any incidence of maternal bradycardia (heart rate&lt;60/min) will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>need for atropine</measure>
    <time_frame>intraoperative</time_frame>
    <description>any need for atropine during the operation because of bradycardia will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modification or cessation of the infusion</measure>
    <time_frame>intraoperative</time_frame>
    <description>any requirement for modification or cessation of the infusion due to reactive hypertension or bradycardia will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of nausea/vomiting</measure>
    <time_frame>intraoperative</time_frame>
    <description>any occurence of nausea and/or vomiting during the operation will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Apgar score at 1 min</measure>
    <time_frame>1 min post delivery</time_frame>
    <description>Neonatal Apgar score will be recorded at 1 min after delivery. The Apgar score is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10. Scores 7 and above are generally normal; 4 to 6, fairly low; and 3 and below are generally regarded as critically low and cause for immediate resuscitative efforts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Apgar score at 5 min</measure>
    <time_frame>5 min post delivery</time_frame>
    <description>Neonatal Apgar score will be recorded at 5 min after delivery. The Apgar score is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10. Scores 7 and above are generally normal; 4 to 6, fairly low; and 3 and below are generally regarded as critically low and cause for immediate resuscitative efforts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neonatal blood gases</measure>
    <time_frame>1 min post delivery</time_frame>
    <description>fetal cord blood analysis will be performed immediately post-delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glucose in neonatal blood</measure>
    <time_frame>1 min post delivery</time_frame>
    <description>glucose will be measured in the cord blood gas sample taken immediately post-delivery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Hypotension</condition>
  <condition>Obstetric Anesthesia Problems</condition>
  <condition>Cesarean Section Complications</condition>
  <condition>Hypotensive</condition>
  <condition>Vasoconstriction</condition>
  <arm_group>
    <arm_group_label>norepinephrine infusion and colloid preloading (NOR-COL)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in parturients allocated to the NOR-COL group, a norepinephrine infusion will be started as soon as spinal anesthesia is initiated. This group will also receive colloid preloading (5 mL/kg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>norepinephrine infusion and crystalloid co-loading (NOR-CRYS)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in parturients allocated to the NOR-CRYST group, a norepinephrine infusion will be started as soon as spinal anesthesia is initiated. This group will also receive crystalloid co-loading (10 mL/kg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>norepinephrine infusion and colloid preloading (NOR-COL)</intervention_name>
    <description>in parturients allocated to the NOR-COL group, a norepinephrine infusion will be started as soon as spinal anesthesia is initiated. This group will also receive 5 mL/kg of colloid infusion prior to the initiation of spinal anesthesia</description>
    <arm_group_label>norepinephrine infusion and colloid preloading (NOR-COL)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>norepinephrine infusion and crystalloid co-loading (NOR-CRYST)</intervention_name>
    <description>in parturients allocated to the NOR-CRYST group, a norepinephrine infusion will be started as soon as spinal anesthesia is initiated. This group will also receive 10 mL/kg of crystalloid infusion simultaneously with the initiation of spinal anesthesia</description>
    <arm_group_label>norepinephrine infusion and crystalloid co-loading (NOR-CRYS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult parturients, American Society of Anesthesiologists (ASA) I-II,&#xD;
&#xD;
          -  singleton gestation&gt;37 weeks&#xD;
&#xD;
          -  elective cesarean section&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Body Mass Index (BMI) &gt;40 kg/m2&#xD;
&#xD;
          -  Body weight &lt;50 kg&#xD;
&#xD;
          -  Body weight&gt;100 kg&#xD;
&#xD;
          -  height&lt;150 cm&#xD;
&#xD;
          -  height&gt;180 cm&#xD;
&#xD;
          -  multiple gestation&#xD;
&#xD;
          -  fetal abnormality&#xD;
&#xD;
          -  fetal distress&#xD;
&#xD;
          -  active labor&#xD;
&#xD;
          -  cardiac disease&#xD;
&#xD;
          -  pregnancy-induced hypertension&#xD;
&#xD;
          -  thrombocytopenia&#xD;
&#xD;
          -  coagulation abnormalities&#xD;
&#xD;
          -  use of antihypertensive medication during pregnancy&#xD;
&#xD;
          -  communication or language barriers&#xD;
&#xD;
          -  lack of informed consent&#xD;
&#xD;
          -  contraindication for regional anesthesia&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kassiani Theodoraki, PhD, DESA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aretaieion University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emmanouil Stamatakis, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alexandra General Hospital of Athens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sofia Hadzilia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alexandra General Hospital of Athens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dimitrios Valsamidis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alexandra General Hospital of Athens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Konstantina Kalopita, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alexandra General Hospital of Athens</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aretaieion University Hospital</name>
      <address>
        <city>Athens</city>
        <zip>115 28</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alexandra General Hospital of Athens</name>
      <address>
        <city>Athens</city>
        <zip>11528</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Afolabi BB, Lesi FE. Regional versus general anaesthesia for caesarean section. Cochrane Database Syst Rev. 2012 Oct 17;10:CD004350. doi: 10.1002/14651858.CD004350.pub3. Review.</citation>
    <PMID>23076903</PMID>
  </reference>
  <reference>
    <citation>KlÃ¶hr S, Roth R, Hofmann T, Rossaint R, Heesen M. Definitions of hypotension after spinal anaesthesia for caesarean section: literature search and application to parturients. Acta Anaesthesiol Scand. 2010 Sep;54(8):909-21. doi: 10.1111/j.1399-6576.2010.02239.x. Epub 2010 Apr 23. Review.</citation>
    <PMID>20455872</PMID>
  </reference>
  <reference>
    <citation>Ngan Kee WD. Prevention of maternal hypotension after regional anaesthesia for caesarean section. Curr Opin Anaesthesiol. 2010 Jun;23(3):304-9. doi: 10.1097/ACO.0b013e328337ffc6. Review.</citation>
    <PMID>20173633</PMID>
  </reference>
  <reference>
    <citation>Kinsella SM, Carvalho B, Dyer RA, Fernando R, McDonnell N, Mercier FJ, Palanisamy A, Sia ATH, Van de Velde M, Vercueil A; Consensus Statement Collaborators. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia. 2018 Jan;73(1):71-92. doi: 10.1111/anae.14080. Epub 2017 Nov 1.</citation>
    <PMID>29090733</PMID>
  </reference>
  <reference>
    <citation>Banerjee A, Stocche RM, Angle P, Halpern SH. Preload or coload for spinal anesthesia for elective Cesarean delivery: a meta-analysis. Can J Anaesth. 2010 Jan;57(1):24-31. doi: 10.1007/s12630-009-9206-7. Epub 2009 Oct 27.</citation>
    <PMID>19859776</PMID>
  </reference>
  <reference>
    <citation>Mercier FJ. Fluid loading for cesarean delivery under spinal anesthesia: have we studied all the options? Anesth Analg. 2011 Oct;113(4):677-80. doi: 10.1213/ANE.0b013e3182245af4.</citation>
    <PMID>21948275</PMID>
  </reference>
  <reference>
    <citation>Li L, Zhang Y, Tan Y, Xu S. Colloid or crystalloid solution on maternal and neonatal hemodynamics for cesarean section: a meta-analysis of randomized controlled trials. J Obstet Gynaecol Res. 2013 May;39(5):932-41. doi: 10.1111/jog.12001. Epub 2013 Feb 4.</citation>
    <PMID>23379937</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 24, 2020</study_first_submitted>
  <study_first_submitted_qc>May 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2020</study_first_posted>
  <last_update_submitted>June 13, 2021</last_update_submitted>
  <last_update_submitted_qc>June 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aretaieion University Hospital</investigator_affiliation>
    <investigator_full_name>Dr Kassiani Theodoraki</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Norepinephrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

